Navigation Links


Transdermal at Biology News

FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain

The Food and Drug Administration (FDA) has granted approval to Mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering from severe chronic pain that cannot be managed with alternative analgesics. When applied to the skin, this patch technology delivers fentanyl, an opioid pain medication that is s...
Transdermal at Biology Products
Transdermal at Biology Technology
Transdermal at Medicine News

Transdermal HRT not cardioprotective in postmenopausal women with CAD

Transdermal hormone replacement therapy (HRT) does not reduce the risk of cardiac events in postmenopausal women with existing coronary artery disease (CAD). In the PHASE trial (Papworth HRT Atherosclerosis Study), researchers randomized 255 postmenopausal women with angiographically proven coronary artery disease to receive either transdermal HRT--17-beta-estradiol with or without cy...

Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease

Transdermal hormone replacement therapy (HRT) does not reduce the risk of cardiac events in postmenopausal women with existing coronary artery disease (CAD). In the PHASE trial (Papworth HRT Atherosclerosis Study), researchers randomized 255 postmenopausal women with angiographically proven coronary artery disease to receive either transdermal HRT--17-beta-estradiol with or without cy...

Transdermal Vaccine Effective in Treating Alzheimer's Disease in Mice

University of South Florida researchers report that a novel needle-free vaccine approach// is effective and safe in clearing brain-damaging plaques from a mouse model of Alzheimer’s disease. The transdermal, or across the skin, vaccination, may offer a simpler way of preventing or treating the devastating neurodegenerative disease with less likelihood of adverse immune reactions. <br...
Transdermal at Medicine Products
Transdermal at Medicine Technology

TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

LOD, Israel--(BUSINESS WIRE)--Jul 9, 2007 - TransPharma MedicalLtd., a specialty pharmaceutical company focused on the developmentand commercialization of drug products utilizing a proprietaryactive transdermal drug delivery technology, announced todaypromising results of its phase I clinical trials demonstrating thesafety and pharmacokinetic profile of its ViaDerm-hPTH (1-34)product for th...

NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Jun 8, 2007 - NuPathe Inc., aprivately held specialty pharmaceutical company, today announcedpositive results from an initial Phase I study of NP101SmartRelief, a novel treatment for acute migraine being developedby NuPathe. NP101 combines NuPathe's SmartRelief(TM) proprietaryiontophoretic transdermal technology with sumatriptan, the mostwidely prescri...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

SAN DIEGO, May 23, 2007 /PRNewswire-FirstCall/ -- Shire plcannounced today that DAYTRANA(TM) (methylphenidate transdermalsystem), its Attention Deficit Hyperactivity Disorder (ADHD) patch,had significant efficacy in reducing the symptoms of ADHD in bothmale and female children aged 6 to 12 years, according to clinicaltrial results reported at the American Psychiatric Association(APA) ann...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

SAN DIEGO, May 23, 2007 /PRNewswire-FirstCall/ -- Shire plcannounced that DAYTRANA(TM) (methylphenidate transdermal system),the first and only non-oral medication approved for treatment ofAttention Deficit Hyperactivity Disorder (ADHD) in children aged 6to 12 years, provided significant improvement in symptom controland tolerability, according to results of a 12-month open-labelstudy pre...

Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter

MELBOURNE, Australia, May 03, 2007 /PRNewswire-FirstCall/ --Phosphagenics Limited (AIM: PSG) announced today that the Companyintends to initiate a Phase 1b clinical trial to demonstrate theefficacy and safety of the improved formulation of its transdermalinsulin product, TPM-02/Insulin, containing long-acting insulin.The trial is expected to commence in the second quarter of2007....
Other TagsPersistEmphasize
(Date:8/21/2008)... IL, Aug. 21 /PRNewswire-FirstCall/ - SXC Health S...SXCI , TSX: SXC), a leading provider of,pharmacy b...hierer,President and CEO, and Jeff Park, CFO, wil...hcare Conference at the Four Seasons Hotel in Bost...ace on Wednesday, September,3, 2008 at 2:40 pm ET....
(Date:8/21/2008)... Flu Vaccination Awareness Campaign...Electing a President is Not the Only Important Cho...aithersburg, MD (PRWEB) August 21, 2008 -- A new s...at vaccination ranks next to last among things the...influenza virus. Although public health guidelines...
(Date:8/21/2008)...ous Coalition for Reproductive Choice at the Democ...RNewswire-USNewswire/ -- RCRC -- the Religious,Coa...ents at the Democratic,National Convention to high...s in the campaign. RCRC,s president, The Reverend ...d is also available for media,interviews. RCRC is ...
(Date:8/21/2008)...IA BEACH, Va., Aug. 21, 2008 /PRNewswire/ -- The A...p. Sylvester Turner of Houston has,been honored wi...is part of the AMERIGROUP Foundation,s national pr...rts by government and community,leaders in improvi...t our,nation., "Our goal is to work together with...
Breaking Medicine News(10 mins):Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 2Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 3Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 4Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 5Health News:Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation 2
(Date:8/21/2008)...ol from 6-11 September, bringing over 350 of the U...test developments in science with the public. In a...Liverpool, there will be a host of events througho...ture celebrations. , Each year, the Festival gen...ond. , Here is just a taster of what,s to come ...
(Date:8/21/2008)...key appetite control cells in the human brain dege...entially weight-gain as we grow older. , The res...ith Monash University,s Department of Physiology, ...nd that appetite-suppressing cells are attacked by...ion is more significant following meals rich in ca...
(Date:8/20/2008)...isn,t just for capturing detailed images of the bo... technology developed by Carnegie Mellon Universit...ize with "exquisite" specificity cell population...on-invasively locate and track cells, such as immu... of cancer, inflammation, and autoimmune diseases,...
(Date:8/20/2008)... a strawberry-flavored banana? Biochemists at The ...the day may be coming when scientists will be able...ruits and vegetables. In addition, it could lead t...e advance online publication of Nature on Aug. 2...n, Ph.D., and his colleagues report that they were...
Breaking Biology News(10 mins):Forward planning release from the BA 2Killer carbs -- Monash scientist finds the key to overeating as we age 2Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body 2Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body 3Biochemists manipulate fruit flavor enzymes 2Cancer patients to be treated by qualified professionals 7411 1Cancer patients to be treated by qualified professionals 7411 2Story ideas from the Journal of Lipid Research 1428 1Story ideas from the Journal of Lipid Research 1428 2Story ideas from the Journal of Lipid Research 1428 3Fever May Improve Behavior of Children With Autism Disorders 7406 1Fever May Improve Behavior of Children With Autism Disorders 7406 2Fever May Improve Behavior of Children With Autism Disorders 7406 3UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 2038 1UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 2038 2UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 2038 3UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 2038 4
Other Contentserythematosuserythematosuserythematosuserythematosuserythematosuslupuslupuslupuslupuslupussystoletachypneapowderpowderpowderpowderpowderpowderpowdertalcum